San-Juan Rafael, Viedma Esther, Chaves Fernando, Lalueza Antonio, Fortún Jesús, Loza Elena, Pujol Miquel, Ardanuy Carmen, Morales Isabel, de Cueto Marina, Resino-Foz Elena, Morales-Cartagena Alejandra, Rico Alicia, Romero María P, Orellana María Ángeles, López-Medrano Francisco, Fernández-Ruiz Mario, Aguado José María
Emerg Infect Dis. 2016 Jun;22(6):1057-66. doi: 10.3201/eid2206.151709.
We investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011-June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 μg/mL and 0.5 μg/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications.
我们调查了抗葡萄球菌药物的高最低抑菌浓度(MIC)在甲氧西林敏感金黄色葡萄球菌导管相关血流感染(MSSA CRBSI)患者中的预后作用。我们前瞻性地回顾了2011年4月至2014年6月期间西班牙5个中心的83例病例,这些病例均有优化的临床管理,并通过多变量分析来研究万古霉素、达托霉素、苯唑西林和利奈唑胺的E试验MIC与复杂性菌血症发生之间的关系。26例(31.3%)患者发生了复杂性MSSA CRBSI;这些患者的万古霉素和达托霉素MIC更高(预测准确性的最佳临界值分别为1.5μg/mL和0.5μg/mL)。万古霉素(风险比2.4,95%置信区间1.2 - 5.5)和达托霉素(风险比2.4,95%置信区间1.1 - 5.9)的高MIC是发生复杂性MSSA CRBSI的独立危险因素。我们的数据表明,由对万古霉素或达托霉素具有高MIC的菌株引起的MSSA CRBSI患者发生并发症的风险增加。